Garg Nita, Professor & Head, Dept. Biochemistry, Shri Guru Ram Rai Institute of Medical & Health Sciences, Patel Nagar, Dehradun, Uttarakhand 248001, India. , Manish Abhinav1 , Garg Nita2 , Sharma Narotam3 , Gupta Ishita4
Aim: To evaluate the diagnostic utility of Serum Cancer Antigen-125 (CA125) and Carcino embryonic antigen (CEA) and LDH levels in patients suffering from Ovarian Cancer.
Study Design: A hospital based cross sectional study was conducted on patients attending the Out Patient Department of Gynecology of SGRR Medical College Dehradun (Uttarakhand) during a period of 8 months from June 2017 to January 2018. A total number of 70 cases of ovarian cancer etween the age group 15-75years were selected randomly for the study.
Inclusion criteria: all patients underwent a tertiary transabdominal and transvaginal sonography and 70 cases of ovarian cancer were selected for the study.
Exclusion criteria: was age less than 15 years and more than 75 years, pregnant women, other Gynecological malignancies, TB, Diabetic Mellitus etc.
Methodology: All the selected cases of ovarian cancer were subjected to clinical chemistry analysis of serum CA 125, CEA & LDH which was performed on fully automated analyzer 5600 of Orthoclinical Diagnostics.
Result: The serum levels of CA125, CEA and LDH were found to be very high along with a high CA125/CEA ratio. Conclusion: Our results show the importance of CA125, CEA, CA125/ CEA ratio and LDH in the diagnosis and monitoring the efficacy of treatment. Combination of serum tumour markers in the diagnosis of ovarian malignancy.
No records found.
| Received | Accepted | Published |
|---|---|---|
| N/A | N/A | N/A |
Monday 13 July 2026, 10:19:17 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | N/A |
| Accepted | N/A |
| Published | N/A |